TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20545502

Group type: EXPERIMENTAL
Intervention: Interpersonal therapy (IPT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Antidepressant medication (ADM)
Number of subjects: 120
Study: 18468378

Group type: EXPERIMENTAL
Intervention: Drug reimbursement rate reduction policy
Number of subjects: 0
Study: 15998783

Group type: EXPERIMENTAL
Intervention: Pancreatic polypeptide (PP) infusion at 0.75 or 2.25 pmol/kg.min
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pancreatic polypeptide (PP) infusion at 2.25 pmol/kg.min
Number of subjects: 14
Study: 12401734

Group type: EXPERIMENTAL
Intervention: Self-monitoring blood glucose device with standardized counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with nonstandardized counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-monitoring blood glucose device
Number of subjects: 0
Study: 10419803

Group type: EXPERIMENTAL
Intervention: Abnormal Uterine Doppler Velocimetry (Ut.DV) defined as (left and right systolic)/diastolic ratio >2.6 and diastolic notching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Normal Uterine Doppler Velocimetry (Ut.DV)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Abnormal Uterine Doppler Velocimetry (Ut.DV) in normotensive and hypertensive pregnancies
Number of subjects: 90
Study: 7568635

Group type: EXPERIMENTAL
Intervention: diazepam 0.2 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: diazepam 0.3 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: lorazepam 0.026 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: lorazepam 0.038 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 2247550

Group type: EXPERIMENTAL
Intervention: Attention directed to right-field flashes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Attention directed to left-ear tones
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Attention directed to either modality
Number of subjects: 20
Study: 6446691

Group type: EXPERIMENTAL
Intervention: Aminooxyacetic acid (AOAA) at a dosage of 2 mg per kilogram per day
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Aminooxyacetic acid (AOAA) for 4 months
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Aminooxyacetic acid (AOAA)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 7
Study: 6408155

Group type: EXPERIMENTAL
Intervention: Nomifensine (200 mg po)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30502656

Group type: EXPERIMENTAL
Intervention: 1975 Japanese diet (JD)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Modern Japanese diet (MD)
Number of subjects: 21
Study: 29526832

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 10142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10142
Study: 27114361

Group type: EXPERIMENTAL
Intervention: Multi-component educational intervention including online lectures, videos, and hands-on experience.
Number of subjects: 89

Group type: COMPARATOR
Intervention: Traditional lecture-based education (Control group).
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Simulation workshop for intervention group participants.
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Pre- and post-intervention surveys for both groups.
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Virtual online clinical exam for all participants.
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Self-reported data on referral patterns.
Number of subjects: 89
Study: 24895878

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (n = 167)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Intravenous tissue-plasminogen activator (IV tPA) (n = 52)
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (n = 190)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Intravenous tissue-plasminogen activator (IV tPA) (n = 92)
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (n = 46)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Intravenous tissue-plasminogen activator (IV tPA) (n = 23)
Number of subjects: 656
Study: 22848340

Group type: EXPERIMENTAL
Intervention: New mother-child play activity program (10 min a day, 5 days a week for 3 months)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 238
Study: 20530662

Group type: EXPERIMENTAL
Intervention: Screening with ultrasound central anterior chamber depth (cACD) < 2.53 mm
Number of subjects: 4597

Group type: COMPARATOR
Intervention: No screening (control group)
Number of subjects: 4597
Study: 18781875

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV7)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control vaccine (Meningococcal conjugate vaccine against serogroup C)
Number of subjects: 0
Study: 15838889

Group type: EXPERIMENTAL
Intervention: Dual therapy (TAC + corticosteroids)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Triple therapy (TAC + corticosteroids + AZA)
Number of subjects: 180
Study: 12492189

Group type: EXPERIMENTAL
Intervention: Variable Stiffness Colonoscope (VSC)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Conventional Colonoscope (CC)
Number of subjects: 467
Study: 10458221

Group type: EXPERIMENTAL
Intervention: Epirubicin 200 mg/m2 and cyclophosphamide 4 g/m2 with progenitor cell and filgrastim support every 28 days (n = 79) or 21 days (n = 20)
Number of subjects: 99
Study: 7734907

Group type: EXPERIMENTAL
Intervention: Elemental diet
Number of subjects: 58

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 58
Study: 2140439

Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 7318882

Group type: EXPERIMENTAL
Intervention: Thiopental 3 mg/kg intravenously
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Diazepam 0.3 mg/kg for sleep induction
Number of subjects: 57

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 57

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 57
Study: 31563384

Group type: EXPERIMENTAL
Intervention: Walking meditation (WM) for 8 weeks, 30 min/day, 3 days/week
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 58
Study: 29208829

Group type: EXPERIMENTAL
Intervention: Phacoemulsification (PKE) in Group A (pupil size <5 mm)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Phacoemulsification (PKE) in Group B (pupil size 5‐7 mm)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Phacoemulsification (PKE) in Group C (pupil size >7 mm)
Number of subjects: 150
Study: 26620555

Group type: EXPERIMENTAL
Intervention: Transumbilical single incision plus one port laparoscopic surgery (SILS plus one)
Number of subjects: 198
Study: 23252715

Group type: EXPERIMENTAL
Intervention: Group LI: ultrasound-guided SNB using long axis view of SN and in-plane insertion of the needle
Number of subjects: 120

Group type: COMPARATOR
Intervention: Group SI: ultrasound-guided SNB using short axis view of SN and in-plane insertion of the needle
Number of subjects: 120

Group type: COMPARATOR
Intervention: Group LO: ultrasound-guided SNB using long axis view of SN and out-of-plane insertion of the needle
Number of subjects: 120

Group type: COMPARATOR
Intervention: Group SO: ultrasound-guided SNB using short axis view of SN and out-of-plane insertion of the needle
Number of subjects: 120
Study: 21756843

Group type: EXPERIMENTAL
Intervention: Rehabilitative online education (N = 29) for five weeks with professional audiologist contact
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (N = 30) - online discussion forum without audiologist contact
Number of subjects: 59
Study: 18713091

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation programme
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no pulmonary rehabilitation)
Number of subjects: 78
Study: 16789980

Group type: EXPERIMENTAL
Intervention: Intravenous albumin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Noradrenaline
Number of subjects: 40
Study: 14504869

Group type: EXPERIMENTAL
Intervention: Inhibin B <1200 pg/ml
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Inhibin B >1200 pg/ml
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cumulus oocyte complexes
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Metaphase II oocytes
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Inhibin B
Number of subjects: 31

Group type: COMPARATOR
Intervention: Classical parameters (Estrogen, FSH, LH)
Number of subjects: 31
Study: 11014391

Group type: EXPERIMENTAL
Intervention: Morphine (MO) plus Flumazenil (FL) (MO 2 mg + FL 0.2 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Morphine (MO) only (MO 2 mg)
Number of subjects: 36
Study: 9048715

Group type: EXPERIMENTAL
Intervention: Chronic fatigue syndrome without psychiatric comorbidity
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chronic fatigue syndrome with psychiatric disease
Number of subjects: 36
Study: 8514472

Group type: EXPERIMENTAL
Intervention: Minocycline hydrochloride injection after cyst aspiration
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (aspirated without minocycline hydrochloride injection)
Number of subjects: 154
Study: 3545942

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (intramuscularly administered)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29893791

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 63

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 63
Study: 28315134

Group type: EXPERIMENTAL
Intervention: Genomic carrier screening
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Logistical issues related to genomic carrier screening
Number of subjects: 240
Study: 25660821

Group type: EXPERIMENTAL
Intervention: Geranylgeranylacetone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (diclofenac sodium only)
Number of subjects: 40
Study: 23536417

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Exercise (PRE)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Stretching, balance, and strengthening exercise program (mFC)
Number of subjects: 51
Study: 21406717

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 241

Group type: COMPARATOR
Intervention: Fludarabine plus cyclophosphamide (FC)
Number of subjects: 241
Study: 18163431

Group type: EXPERIMENTAL
Intervention: Keys to Caregiving Program
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 13
Study: 16552548

Group type: EXPERIMENTAL
Intervention: Osteochondral autologous transplantation (OAT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Microfracture (MF)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: OAT
Number of subjects: 57

Group type: COMPARATOR
Intervention: MF
Number of subjects: 57
Study: 14667889

Group type: EXPERIMENTAL
Intervention: DHEA (25 mg/d orally)
Number of subjects: 20
Study: 12666979

Group type: EXPERIMENTAL
Intervention: Low dose doxycycline (20 mg, b.i.d.)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (inactive filler; starchflour, b.i.d.)
Number of subjects: 15
Study: 8617118

Group type: EXPERIMENTAL
Intervention: Omeprazole delivered orally
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Omeprazole delivered via nasogastric tube
Number of subjects: 10
Study: 1571877

Group type: EXPERIMENTAL
Intervention: Time to Quit (TTQ) self-help cessation program
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group (community smoking cessation resources)
Number of subjects: 307
Study: 3909374

Group type: EXPERIMENTAL
Intervention: Ranitidine, 300 mg daily
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Ranitidine, 100 mg twice daily or 150 mg at night
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 30298416

Group type: EXPERIMENTAL
Intervention: Low flow rate (1 L/min) for induction followed by high flow rate (10 L/min) for maintaining 12 mmHg pneumoperitoneum (group A)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Continuous high flow rate group (group B)
Number of subjects: 140
Study: 29995726

Group type: EXPERIMENTAL
Intervention: Prophylactic negative pressure wound therapy
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard surgical dressings
Number of subjects: 166
Study: 27697330

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (study formula)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Nutritional supplementation (study formula) in 'good' consumers initially randomized to placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (study formula) in 'poor' consumers
Number of subjects: 150
Study: 25299647

Group type: EXPERIMENTAL
Intervention: Standard opt-in invitation
Number of subjects: 1172

Group type: EXPERIMENTAL
Intervention: Active choice invitation
Number of subjects: 1172

Group type: EXPERIMENTAL
Intervention: Enhanced active choice invitation
Number of subjects: 1172
Study: 22009219

Group type: EXPERIMENTAL
Intervention: Selective photocoagulation (S‐PC)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Non-photocoagulation (non-PC group)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 69
Study: 20361377

Group type: EXPERIMENTAL
Intervention: MESH catheter
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (three-dimensional mapping system guided ablation)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 17981375

Group type: EXPERIMENTAL
Intervention: Walking at different intensities (67/0; 93.8/0; and 93.8 m min(‐1)/2.5% slope)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Walking at the highest intensity
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Walking EE estimated using MET codes
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Walking at ground level
Number of subjects: 58
Study: 16095529

Group type: EXPERIMENTAL
Intervention: MCP-1 levels in children with ILD
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CCR2+ T cells in children with ILD
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MCP-1 levels in children with lung fibrosis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CCR2+ T cells in children with lung fibrosis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Correlation of MCP-1 and CCR2+ T cells with lung function
Number of subjects: 25
Study: 12417542

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 4284

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4284
Study: 10511436

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 7741291

Group type: EXPERIMENTAL
Intervention: Mean skin temperature maintained near 31, 34, 35, 36, and 37 degrees C in men; 31, 35, and 37 degrees C in women.
Number of subjects: 12
Study: 8252269

Group type: EXPERIMENTAL
Intervention: Early mobilisation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Bed rest
Number of subjects: 61
Study: 3546144

Group type: EXPERIMENTAL
Intervention: Amikacin plus piperacillin plus trimethoprim/sulphamethoxazole
Number of subjects: 161

Group type: COMPARATOR
Intervention: Amikacin plus piperacillin
Number of subjects: 161
Study: 30670642

Group type: EXPERIMENTAL
Intervention: Levodopa (dopamine precursor)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Risperidone (dopamine antagonist)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 27
Study: 29750651

Group type: EXPERIMENTAL
Intervention: Depot leuprolide acetate (LA Depot) every 3 months for up to 42 months
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Depot leuprolide acetate (LA Depot)
Number of subjects: 71
Study: 27026148

Group type: EXPERIMENTAL
Intervention: AERAS-402
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24989920

Group type: EXPERIMENTAL
Intervention: Preoperative embolization
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional tumor resection
Number of subjects: 68
Study: 22152978

Group type: EXPERIMENTAL
Intervention: Exercise training (10 sessions)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 27
Study: 20557406

Group type: EXPERIMENTAL
Intervention: Mutual peer review intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Change diaries used to record progress
Number of subjects: 100
Study: 18686771

Group type: EXPERIMENTAL
Intervention: Prefabricated fiber post (DT Light Post)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Customized fiber post (Ever Stick Post)
Number of subjects: 345

Group type: COMPARATOR
Intervention: No root canal retention
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Teeth retaining one coronal wall
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Teeth retaining two coronal walls
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Teeth retaining three coronal walls
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Teeth missing all coronal walls
Number of subjects: 345
Study: 16044962

Group type: EXPERIMENTAL
Intervention: MMC + HCFU (300 mg/day orally for one year)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: MMC + UFT (300 mg/day or 400 mg/day orally for one year)
Number of subjects: 501
Study: 12644340

Group type: EXPERIMENTAL
Intervention: Invasive therapy (coronary angiography and revascularization when feasible) with tirofiban (for 48 h) plus aspirin and heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment (angiography only for patients with recurrent ischemia at rest or a positive stress test) with tirofiban (for 48 h) plus aspirin and heparin
Number of subjects: 0
Study: 9640159

Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine 1.0 ml kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.375% bupivacaine 1.0 ml kg‐1
Number of subjects: 60
Study: 7914845

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study: 3067954

Group type: EXPERIMENTAL
Intervention: Nifedipine retard
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (age-and-sex-matched)
Number of subjects: 15
Study: 30292242

Group type: EXPERIMENTAL
Intervention: Use of decision aids (15 consultations)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care (21 consultations)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall patient involvement
Number of subjects: 36
Study: 28264588

Group type: EXPERIMENTAL
Intervention: E‐Learning Plus communication partner training (CPT) programme
Number of subjects: 48

Group type: COMPARATOR
Intervention: Supported Conversation for Adults with Aphasia (SCATM) CPT programme
Number of subjects: 48
Study: 23572471

Group type: EXPERIMENTAL
Intervention: Trans-cultural concept for alcohol prevention
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 176
Study: 24180628

Group type: EXPERIMENTAL
Intervention: Brinzolamide 1%/Timolol 0.5% (Brinz/Tim)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Dorzolamide 2%/Timolol 0.5% (Dorz/Tim)
Number of subjects: 114
Study: 21429992

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 883

Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 883
Study: 18808424

Group type: EXPERIMENTAL
Intervention: Levetiracetam therapy
Number of subjects: 21
Study: 16929703

Group type: EXPERIMENTAL
Intervention: Children with BECTS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group of healthy children
Number of subjects: 26
Study: 12923822

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study: 11137250

Group type: EXPERIMENTAL
Intervention: AlPO(4)‐adjuvated vaccine/2+1 schedule
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: AlPO(4)‐adjuvated vaccine/3+1 schedule
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Al(OH)(3)‐adjuvated vaccine/2+1 schedule
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Al(OH)(3)‐adjuvated vaccine/3+1 schedule
Number of subjects: 134
Study: 9085953

Group type: EXPERIMENTAL
Intervention: Hydromorphone (HM) 0.075 mg/mL + Nalbuphine (NB) 0.04 mg/mL
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Hydromorphone (HM) 0.075 mg/mL + Nalbuphine (NB) 0.02 mg/mL
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Hydromorphone (HM) 0.075 mg/mL + Nalbuphine (NB) 0.08 mg/mL
Number of subjects: 78

Group type: COMPARATOR
Intervention: Hydromorphone (HM) 0.075 mg/mL
Number of subjects: 78
Study: 8280544

Group type: EXPERIMENTAL
Intervention: Diamorphine 2.5 mg in saline 10 ml
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Diamorphine 2.5 mg in 1:200,000 adrenaline 10 ml
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline 10 ml (Control)
Number of subjects: 45
Study: 3551972

Group type: EXPERIMENTAL
Intervention: TAD consolidation with monthly maintenance chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAD consolidation without monthly maintenance chemotherapy
Number of subjects: 0
Study: 31317471

Group type: EXPERIMENTAL
Intervention: 200 μg/day selenium supplements as selenium yeast
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 30291841

Group type: EXPERIMENTAL
Intervention: Singing intervention with health messages regarding antenatal care, presented through songs and dances, and supported by a wall chart with key health messages.
Number of subjects: 1510

Group type: COMPARATOR
Intervention: Control group with no significant intervention.
Number of subjects: 1510

Group type: EXPERIMENTAL
Intervention: Singing intervention among the most illiterate members of the community.
Number of subjects: 1510

Group type: EXPERIMENTAL
Intervention: Post-intervention follow-up at 12 months.
Number of subjects: 1510